Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      • Home
      • Meghna A Singhania

      Articles By : Meghna A Singhania

      Star Health crosses Rs 2,000 crore Gross Written Premium in 2015-16

      Star Health crosses Rs 2,000 crore Gross Written Premium in 2015-16

      Meghna A Singhania10 April 2016 2:03 PM IST
      Chennai: Private health insurer Star Health and Allied Insurance has crossed Gross Written Premium (GWP) of Rs 2,000 crore in 2015-16, up by 36 per...
      Sun Pharma gets USFDA nod for eye inflammation drug

      Sun Pharma gets USFDA nod for eye inflammation drug

      Meghna A Singhania10 April 2016 1:55 PM IST
      New Delhi, Apr 10: Drug major Sun Pharmaceutical Industries has received approval from the US health regulator for its non-steroid drug BromSite used...
      Himalaya aims to bulk up distribution, double sales by 2020

      Himalaya aims to bulk up distribution, double sales by 2020

      Meghna A Singhania10 April 2016 12:55 PM IST
      Mumbai: Herbal health and personal care firm Himalaya Drug Company is looking to bulk up its distribution network across verticals as it eyes doubling...
      USFDA comes out with draft industry guidance on abuse- deterrent opioid generics

      USFDA comes out with draft industry guidance on abuse- deterrent opioid generics

      Meghna A Singhania27 March 2016 9:51 AM IST
      n"The U.S. Food and Drug Administration issued draft guidance on Thursday for abuse-deterrent opioid generics, including a recommendation that studies...
      FDA Approval granted to Zydus Cadilla for Ahemdabad Plant

      FDA Approval granted to Zydus Cadilla for Ahemdabad Plant

      Meghna A Singhania24 Feb 2016 4:31 PM IST
      Zydus Cadilla has announced its return to the US business market . Cadilla’s U.S. business was closed down in 2014, when the company was caught for...
      Prev

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok